Chargement en cours...
Targeting Multiple Key Signaling Pathways in Melanoma using Leelamine
Melanoma is a highly drug resistant cancer with resistance developing to agents targeting single proteins. To circumvent this problem, a new class of agent inhibiting multiple key pathways important in this disease is being developed to reduce the likelihood of developing resistant disease. The PI3...
Enregistré dans:
| Publié dans: | Mol Cancer Ther |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4377161/ https://ncbi.nlm.nih.gov/pubmed/24688050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0867 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|